Skip to main content

Table 2 Viral suppression at different threshold, regardless of duration thresholds disaggregated by level of care

From: HIV viral suppression at different thresholds and duration of treatment in the dolutegravir treatment era in Sierra Leone: a nationwide survey

Viral load (copies/mL)

Overall, N = 2253

Primary, N = 601

Secondary, N = 188

Tertiary, N = 1,464

p-value

N

%, 95%CI

N

%, 95%CI

N

%, 95%CI

N

%, 95%CI

< 1000

1,983

88.0 (86.6, 89.3)

511

85.0 (81.9, 87.7)

172

91.5 (86.3, 94.9)

1,300

88.8 (87.0, 90.3)

0.017

< 400

1,927

85.5 (84.0, 86.9)

487

81.0 (77.6, 84.0)

167

88.8 (83.2, 92.8)

1,273

87.0 (85.1, 88.6)

< 0.001

< 200

1,878

83.4 (81.7, 84.9)

477

79.4 (75.9, 82.5)

162

86.2 (80.2, 90.6)

1,239

84.6 (82.7, 86.4)

0.008

< 50

1,672

74.2 (72.3, 76.0)

434

72.2 (68.4, 75.7)

141

75.0 (68.1, 80.9)

1,097

74.9 (72.6, 77.1)

0.4

< 20

1,517

67.3 (65.3, 69.3)

398

66.2 (62.3, 70.0)

124

66.0 (58.7, 72.6)

995

68.0 (65.5, 70.3)

0.7